Wambolt & Associates, LLC Novo Nordisk A S Transaction History
Wambolt & Associates, LLC
- $333 Million
- Q1 2024
A detailed history of Wambolt & Associates, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wambolt & Associates, LLC holds 30,270 shares of NVO stock, worth $4.32 Million. This represents 1.17% of its overall portfolio holdings.
Number of Shares
30,270
Previous 25,716
17.71%
Holding current value
$4.32 Million
Previous $2.66 Million
46.09%
% of portfolio
1.17%
Previous 0.47%
Shares
7 transactions
Others Institutions Holding NVO
# of Institutions
1,854Shares Held
309MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$3.01 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.96 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.86 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.71 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.69 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $322B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...